Introduction DURING the past 25 years numerous outbreaks of a cholera-like disease, usually referred toasparacholera, have occurred in Indonesia (Pollitzer 1959) . This disease is clinically indistinguishable from classical cholera and a redefinition, by World Health Organization, of" cholera" now includes cholera El Tor (World Health Organization 1962) .
In the last 100 years cholera has disappeared from Europe and Africa and gradually receded to two localized endemic areas which by 1960 consisted of the Rivers Ganges and Brahmaputra delta for Vibrio cholerae and the Island of Celebes for Vibrio el tor (World Health Organization 1965) .
From 1961 onwards cholera El Tor has rapidly increased its geographic range at first eastwards and later westwards until by 1965 Investigations into some of these outbreakS revealed two alarming features; firstly that, in the areas where it occurred, infection with. V. el tor was commonplace with comparatively few typical cases of cholera and secondly, there were many carriers, some of whom excreted the organism for up to three years. Convalescents, normally stoolnegative, when purged or when suffering from intercurrent diarrhoea, were shown to excrete V. el tor.
There appears to be a significant risk that in the near future expansion of cholera . El Tor could continue, due, not only to pilgrimages and migrations in the Middle East where sanitation standards are not as' effective as in Europe, but also to modern rapid transport methods and immigration from the East, giving rise to family infections and localized outbreaks in Europe itself.
Vibrio el tor Paracholera is caused by Vibrioeltor, an organism which has many characteristics in common with Vibrio cholerae, the causative organism of classical asiatic cholera. Both organisms have identical morphology and cultural characteristics, belong to the Heiberg fermentati~n group I apd share common 0 group antigens.
A number of differences between the two vibrios have been described; haemolyti<;: THE SPREAD OF CHOLERA EL TOR 1961 Fugure 1. The hatched area represents the endemic area for classical cholera and the black island (Celebes) represents the endemic area for cholera El Tor in 1960, adapted from W.H.O. Chronicle (1966), 20, 263. activity, toxin, protein composition, sublimate precipitation, soda agglutination, Voges Proskauer reaction and heat and chl6roform inactivation of agglutinability (PoIlitzer 1959) . Bacteriophage typing (Mukerjee 1961), haemolysin testing either as recommended by Feeley and Pittman (1963) or chicken red-cell agglutination test (Finkelstein and Mukerjee 1963) , and mouse toxicity (Noble 1964a) provide concise methods of differentiating the two vibrios.
Vaccination against cholera
The first worker to demonstrate the possibility of an actively induced immunity group.bmj.com on September 26, 2017 -Published by http://jramc.bmj.com/ Downloaded from against cholera was Ferran in 1885. During the 1884 outbreak of cholera in Spain, he was able to demonstrate that guinea-pigs, which survived inoculation with a bile broth culture of live cholera vibrios, were resistant to the administration of further doses lethal to unprotected animals. Gamaleia (1888) showed that it was possible to protect guinea-pigs against lethal doses of V. cholerae not only with live organisms of reduced virulence, but also with organisms killed by heating at 120°C. Many workers continued to experiment with living vaccines until Kolle (1896), using a cholera vaccine prepared by heating a suspension of cholera culture ~t 56°C. for one hour, showed that the bactericidal properties of sera obtained from human volunteers were as high, if not higher, ten days after one injection of this vaccine than those obtained after a course of three injections of live cholera vaccine.
In the years that followed many workers continued experimenting with one' form of cholera vaccination or another. These experiments included:-live vaccines with cholera strains of decreased virulence; inactivated vaccines in which the organisms were killed by various methods including heat, chloroform, phenol and formalin; whole fluid-culture vaccines in which the vibrios were grown on casein hydrolysate medium, killed by formolization and injected in entirety; vac;cination with supernatants, filtrates and autolysates of cholera cultures; cholera formol toxoids; and attempts at vaccination by both the ihtranasal and oral routes. The outcome of all this work was that, by the 1950's, a series of almost universally accepFable standards for the production of a heat-killed phenol-preserved divalent cholera vaccine containing 8,000 million organisms per ml. had been evolved. These standards, which include the nature, virulence and serotype of the vibrio;', methods of culture and inactivation, and recommended techniques for assaying the resultant cholera vaccine, were laid down by W orId Health Organization (1959) .
Although cholera vaccine was tne first bacterial vaccine to be introduced for the' control of communicable disease in man no proper evaluation has been made in a strictly controlled field trial until recently. Indeed, although it has been widely used for 80 years there has been no proof as to its efficacy. Under the auspice~ of S.E.A.T.O. Oseasohn, Benenson and Fahimuddin (1965) carried. out a field trial in rural East Pakistan using a classical divalent cholera vaccine described in detail'by Feeley and Pittman (1965) . These authors state: " During the first year of a double-field trial of a cholera vaccine in an endemic area, the incidence of diarrhoea associated with V. cholerae was 6.1 per 1,000 among controls given a T.A.B. vaccine, and 1.7 per 1,000 amongst subjects given commercial cholera vaccine of high potency." It would thus appear that the efficacy of cholera vaccine in protecting against V. cholerae has at last been proven.
In recent years several authors have advocated the administration of cholera vaccine by the intradermal route. Singer, Wei and Hoa (1948) found that better antibody production was obtained by this method of vaccination and Panja and Das (1947) , whilst noting the economy of materials and negligible reactions resulting from intradermal cholera vaccination, considered the method impracticable in mass inoculation programmes: Noble (1964b) found that the protection afforded by cholera vaccine administered by the intradermal route and demonstrated by active and passive mouse-protection tests,active guinea-pig tests, and antibody responses in both rabbit and man,was excellent and equal to that given by subcutaneous inoculations. He found that intradermal inoculation 'greatly reduced the incidence of reactions to cholera vaccine and was a practical proposition when the rapid immunization of large numbers was necessary.
Vaccination and the ErTor Vibrio
Vaccination and the El Tor vibrio Mukerjee and Guha Roy(1962), Felsenfeldet al (1962) and the author of a leading article in the British Medical Journal (1962) have suggested that classical cholera vaccine may be of doubtful value for mass immunization against outbreaks of El Tor cholera. This view has again been expressed by the author of a leading article' in the British Medical Journal (1965) and by Mukerjee et al (1965) . Feeley and Pittman (1963), Vella (1963) and Noble (1964a) have shown that classical cholera vaccines are capable of protecting mice against V. el tor to the same degree as against V. cho/dae.
Active and passive protection tests were described by Noble (1965) in which classical cholera vaccine protected laboratory animals as effectively against challenge with the El Tor vibrio as against challenge with V. cholerae. Furthermore in these experiments . the incorporation of V. et tor in cholera vaccine gave no improvement in the protection afforded to animals' challenged with that organism.
In 1965 a field-trial was carried out by the Philippines Cholera Committee. In this trial a classical V. cholerae vaccine, an oil-adjuvant vaccine and a V. el tor vaccine were compared in a controlled field trial on some 584,000 people in an endemic cholera El Tor area in the Philippines. It was shown that cholera vaccines gave moderate protection of short duration. The overall carrier rate was reduced from 12.4 per cent in the controls to 8.2 per cent in vaccinated individuals. Injection of a single dose of vaccine prepared from either V. cholerae or V. el tor gave over 50 per cent protection for the first three to four months. This confirmed the mouse-protection experiments cited above in which cholera vaccination was followed by challenge at seven to ten days.
The immunity conferred by V. cholerae vaccine rapidly declined after four months whereas V. el tor vaccine appeared to give protection for six months before its effectiveness declined. However when all the figures were subsequently analysed the apparent advantage of the El Tor vaccine was found not to be statistically significant. An oiladjuvant vaccine prepared from V. cholerae conferred an increasing degr~e of protection . of longer duration but owing to severe vaccination reactions its use could not be recommended.
In 1964 and 1965 two further cholera vaccine trials, sponsored by the World Health Organization, have taken place in Calcutta where the El Tor vibrio is now the predominant epidemic strain. Both these trials support the view that conventional cholera vaccine gives moderate protection against the El Tor vibrio, that this protection is of short duration and that its effectiveness has waned by six months.
Conclusion
It is not generally realized that the last notifications for cholera in Europe were as recent as: Greece 1922 , Roumania 1922 , Spain and Germany 1921 , Italy 1916 and England 1911 (Pollitzer 1959 . .
The increase in the geographic range of cholera which has occurred during the last five years very closely resembles that shown in the early part of the most recent sixth cholera pandemic of 1899 to 1922 as is shown in table 1. For reasons which are stated earlier there/is a significant risk that cholera could spread further West and involve some parts of Europe. In an article, Mukerjee et al (1965) have suggested that the V. el tor appears to inhibit V. cholerae both in vitro and in vivo and that for this reason the El Tor vibrio is now the principle causative organism of cholera in most areas.
These facts have given rise to a renewed interest in cholera vaccines and to doubts as to whether the conventional divalent cholera vaccines would protect against V. el tor.
Although recent field trials have confirmed that cholera vaccines have a valuable part to play· in the protection of the individual against cholera, the principal defence against this disease must still be by detection of cases and carriers, by the highest standards of hygiene and by health education. There is no doubt that conventional cholera vaccines of high potency protect a.s well against the El Tor vibrio as against V. cholerae; This protectiori is short lived and reinforcement of immunity should take place at intervals of not less than six months. For those in' continued intimate contact with cholera an interval as short as three months should be considered if the maximum benefit is to be derived from vaccination.
Extensive research is contiilUing in America, India, Pakistan and in/this country at the David Bruce Laboratories and elsewhere with conventional cholera vaccines, El Tor vaccines and trivalent vaccines containing both V. cholerae and V. el tor: It is highly probable that in the near future a more effective vaccine of higher potency than those at present in use, yet remaining as free from severe reactions, will be found, in order better to protect the individual against cholera regardless of whether it is caused by V. cholerae or V. el tor. , for investigation of a fever of a few days duration. He had a basal pneumonia which cleared with tetracycline therapy but his temperature remained elevated for four weeks during which he remained well and cheerful, sometimes eating huge meals with a smile on his face and a pyrexia of 105°. During this time his white cell count remained low, his spleen slowly enlarged, and he became progressively -anaemic, down to a level of 7.6 grams per cent. He also developed hyperglobulinaemia. Since we knew he had been in Aden from May to October 1964 leishmaniasis was suspected early, but repeated blood examinations, and marrow and liver biopsies failed to reveal the parasite. However on 19th July treatment with sodium stibogluconate (Pentostam) was started. His fever immediately fell and all abnof!nalities rapidly disappeared. J have no doubt on clinical grounds that he was suffering from visceral leishmaniasis . . He was later fit enough to go with his battalion to Borneo.
LETTERS TO THE EDITOR
He was mostly on convoy guard duty between ADEN and THUMIAR during his stay in Aden. However in July 1964 he spent 3 weeks on patrol in the Radfan area often staying near small villages' and lying on the ground on sand or grass. He also did one convoy up the DHALA road while temporarily attached to the Royal Scots.
. ' , AMD Stats should now be able to produce total numbers of cases of leishmaniasis occurring in British troops-stationed in Aden. This case emphasised once again the importance of taking a careful and detailed history. 
